Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Leslie Citrome, Stuart H Isaacson, Danielle Larson & Daniel Kremens. (2021) Tardive Dyskinesia in Older Persons Taking Antipsychotics. Neuropsychiatric Disease and Treatment 17, pages 3127-3134.
Read now
Read now
Richard Jackson, Matthew N Brams, Leslie Citrome, Amber R Hoberg, Stuart H Isaacson, John M Kane & Rajeev Kumar. (2021) Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations. Neuropsychiatric Disease and Treatment 17, pages 1589-1597.
Read now
Read now
Articles from other publishers (13)
Mei-Chun Lin, Yung-Yee Chang, Yu Lee & Liang-Jen Wang. (2023) Tardive sensory syndrome related to lurasidone: A case report. World Journal of Psychiatry 13:3, pages 126-130.
Crossref
Crossref
Vishnupriya Veeraraghavan & Dinesh Agarwal. (2022) Risperidone induced tardive movements in an elderly male-a case of cognitive decline masked by behavioral abnormalities. Geriatric Care 8:3.
Crossref
Crossref
Ahmad E Rokon, Faisal A Alsomali, Malek A Alrasheed, Abdulrahman D Alharbi, Moustafa S Alhamadh, Abdulmajeed M Alqahtani, Farah K Alhamidy & Meshal R Alotaibi. (2022) Tardive Dyskinesia Following Low-Dose Risperidone. Cureus.
Crossref
Crossref
Aditya Nidumolu, Anthony Pianosi & Claire O'Donovan. (2022) Early onset tardive syndromes associated with Lurasidone in patients with mood disorders: A case series and literature review. Journal of Affective Disorders Reports 10, pages 100423.
Crossref
Crossref
Stanley N. Caroff. (2022) A new era in the diagnosis and treatment of tardive dyskinesia. CNS Spectrums, pages 4-14.
Crossref
Crossref
Yael Barer, Rinat Ribalov, Ayelet Yaari, Ron Maor, Qais Arow, John Logan, Gabriel Chodick, David Arkadir & Renana Eitan. (2022) The Clinical and Economic Burden of Tardive Dyskinesia in Israel. Journal of Clinical Psychopharmacology 42:5, pages 454-460.
Crossref
Crossref
Gurpreet Rekhi, Jenny Tay & Jimmy Lee. (2022) Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia. Journal of Psychopharmacology 36:2, pages 183-190.
Crossref
Crossref
ShreyasShrikant Pendharkar & ShilpaAvinash Telgote. (2022) Lurasidone-induced tardive dyskinesia. Annals of Indian Psychiatry 6:2, pages 184.
Crossref
Crossref
Hiroyoshi Takeuchi, Yasuhiro Mori & Yuichiro Tsutsumi. (2022) Pathophysiology, prognosis and treatment of tardive dyskinesia. Therapeutic Advances in Psychopharmacology 12, pages 204512532211173.
Crossref
Crossref
Leslie Citrome, Lakshmi N. Yatham, Mehul D. Patel, Ágota Barabássy, Arlene Hankinson & Willie R. Earley. (2021) Cariprazine and akathisia, restlessness, and extrapyramidal symptoms in patients with bipolar depression. Journal of Affective Disorders 288, pages 191-198.
Crossref
Crossref
Stanley N. Caroff. (2020) Recent Advances in the Pharmacology of Tardive Dyskinesia. Clinical Psychopharmacology and Neuroscience 18:4, pages 493-506.
Crossref
Crossref
Małgorzata Romaniuk, Konrad Suswał, Aleksandra Skałecka, Maria Gromek, Martyna Kozłowska & Paweł Krukow. (2020) Drug-induced dyskinesias, can they be prevented?. Current Problems of Psychiatry 21:2, pages 95-101.
Crossref
Crossref
Jose de Leon, Can-Jun Ruan, Georgios Schoretsanitis & Carlos De las Cuevas. (2020) A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology. Psychotherapy and Psychosomatics 89:4, pages 200-214.
Crossref
Crossref